Seres Therapeutics Inc

+0.02 (+0.35%)
7:28:42 PM EDT: $5.69 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)719.88M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.1 Million
Adjusted EPS-$0.53
See more estimates
10-Day MA$5.67
50-Day MA$5.41
200-Day MA$5.54
See more pivots

Seres Therapeutics Inc Stock, NASDAQ:MCRB

200 Sidney Street, 4th floor, Cambridge, Massachusetts 02139
United States of America
Phone: +1.617.945.9626
Number of Employees: 333


Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.